Scott Dunseth Myers - 25 Oct 2021 Form 4 Insider Report for Harpoon Therapeutics, Inc.

Role
Director
Signature
/s/ Scott Dunseth Myers by Laura Berezin, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
25 Oct 2021
Net transactions value
$0
Form type
4
Filing time
26 Oct 2021, 16:22:58 UTC
Previous filing
21 Oct 2021
Next filing
19 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Director Stock Option (Right to Buy) Award $0 +10,167 $0.000000 10,167 25 Oct 2021 Common Stock 10,167 $6.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to continuous service, the stock option shall be fully vested and exercisable on the first anniversary of the vesting commencement date, October 25, 2022.